Cost and availability of novel cell and gene therapies: Can we avoid a catastrophic second valley of death?: Can we avoid a catastrophic second valley of death? (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.15252/embr.202256661
PubMed Identifier: 36592141
Publication URI: http://europepmc.org/abstract/MED/36592141
Type: Journal Article/Review
Volume: 24
Parent Publication: EMBO reports
Issue: 2
ISSN: 1469-221X